Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Sanara MedTech ( (SMTI) ) is now available.
On January 21, 2025, Sanara MedTech announced the appointment of Elizabeth B. Taylor as the new Chief Financial Officer, effective January 15, 2025, succeeding Michael D. McNeil, who transitions to Chief Accounting Officer and Chief Administrative Officer. Taylor brings over 25 years of financial experience, enhancing Sanara’s leadership as it seeks growth in its market focus areas. This leadership change signifies the company’s strategic efforts to strengthen its financial operations and market positioning, potentially impacting stakeholders by optimizing the company’s growth and operational progress.
More about Sanara MedTech
Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound, and skincare markets. The company markets and distributes products primarily in the North American advanced wound care and surgical tissue repair markets and offers wound care and dermatology virtual consultation services via telemedicine.
YTD Price Performance: 2.72%
Average Trading Volume: 31,362
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $297.2M
See more insights into SMTI stock on TipRanks’ Stock Analysis page.
